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Abstract The protozoan parasite Leishmania donovani is
the causative agent of visceral leishmaniasis. The enzyme
pteridine reductase 1 (PTR1) of L. donovani acts as a
metabolic bypass for drugs targeting dihydrofolate reduc-
tase (DHFR); therefore, for successful antifolate chemo-
therapy to be developed against Leishmania, it must target
both enzyme activities. Leishmania cells overexpressing
PTR1 tagged at the N-terminal with green fluorescent
protein were established to screen for proprietary dihydro-
pyrimidone (DHPM) derivatives of DHFR specificity
synthesised in our laboratory. A cell-permeable molecule
with impressive antileishmanial in vitro and in vivo oral
activity was identified. Structure activity relationship based
on homology model drawn on our recombinant enzyme
established the highly selective inhibition of the enzyme by
this analogue. It was seen that the leishmanicidal effect of
this analogue is triggered by programmed cell death
mediated by the loss of plasma membrane integrity as
detected by binding of annexin V and propidium iodide
(PI), loss of mitochondrial membrane potential culminating
in cell cycle arrest at the sub-G0/G1 phase and oligonu-
cleosomal DNA fragmentation. Hence, this DHPM
analogue [(4-fluoro-phenyl)-6-methyl-2-thioxo-1, 2, 3, 4-
tetrahydropyrimidine-5-carboxylic acid ethyl ester] is a
potent antileishmanial agent that merits further pharmaco-
logical investigation.
Introduction
The kinetoplastid parasite Leishmania donovani is the causa-
tive agent of visceral leishmaniasis (VL) known as Kala-azar
in India. Over 90% of VL cases occur in India, Bangladesh,
Sudan, Brazil and Nepal (http://www.oneworldhealth.org/
diseases/leishmaniasis.php). The control of leishmaniasis in
absence of vaccine solely depends on the choice of
chemotherapy. Treatment available for VL is far from ideal
(Berman et al. 2006; Sundar and Chatterjee 2006). The
search for development of a new, safe, effective and
inexpensive drug that can cure VL throughout the world
continues. In the search for better therapeutics against VL,
we focused on a validated drug target viz. folate bio-
synthetic pathway which is unique to the parasite (Bello et
al. 1994). The enzyme pteridine reductase 1 (PTR1;
accession no. AY547305) of L. donovani a c t sa sa
metabolic bypass for drugs targeting dihydrofolate reduc-
tase (DHFR); therefore, for successful antifolate chemo-
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DOI 10.1007/s00436-009-1557-ztherapy to be developed against Leishmania, it must target
both enzyme activities. Reduced pterins and folates are
essential for the growth of Leishmania parasites, but anti-
pteridines have not shown much promise clinically against
Leishmania in contrast to other protozoal infections (Hardy
et al. 1997). This establishes the need for continued effort
and research in this direction. Since dihydropyridines and
pyrimidinones (80 thiones) are known inhibitors of DHFR
and exhibit antitubercular activity against Mycobacterium
tuberculosis, a pathogen residing in macrophages like
Leishmania (Küçükgüzel et al. 2007), we were interested
to see whether they exhibit any pteridine reductase
inhibitory activities, and therefore, this study was under-
taken. Dihydropyrimidone (DHPM) analogues have
exhibited important therapeutic and pharmacological prop-
erties as the integral backbone of several calcium channel
blockers (Kappe 2000), antihypertensive agents (Atwal et
al. 1991), α1a-antagonist (Kappe et al. 1997) and neuro-
peptide Yantagonists (Wang et al. 2006). A broad range of
biological effects including antiviral, antitumor, antibacte-
rial and anti-inflammatory activities have been described
for these compounds (Kappe 1993). Further, understanding
the mode of action and binding modes of these DHPM
analogues to specific target sites may be used to design
potent, novel, selective and less toxic antileishmanial
analogues of these compounds on a structural basis. Here,
we report a novel DHPM analogue that is cell permeable and
a potent oral antileishmanial molecule in vivo. We also
sought to determine the mechanism of leishmanicidal
activity of this compound. There are several reports showing
that Leishmania apoptosis occurs in response to antileish-
manial drugs (Wang et al. 2006; Singh et al. 2005). It has
also been demonstrated that the antileishmanial toxicity of
trivalent antimonials is associated with apoptosis (Mann et
al. 2006;S h a h a2006). This analogue induces programmed
cell death (PCD) in Leishmania parasites via externalisa-
tion of phosphatidyl serine involving changes in mitochon-
drial membrane potential leading to DNA fragmentation.
Materials and methods
Materials M-199 medium and foetal bovine serum (FBS)
were obtained from Gibco-BRL, dimethyl sulphoxide
(DMSO) from SRL, ethanol from Merck, propidium iodide
(PI), Annexin V-PE and MitoTracker deep red from
Molecular Probes. All other chemicals were from Sigma
unless stated.
Parasite culture Transgenic parasites overexpressing
PTR1–green fluorescent protein (GFP chimaera, PTR1
tagged at the N-terminal with GFP) were cultured at 25°C
in M-199 medium supplemented with 10% heat-inactivated
FBS, 100 U penicillin, 100μg/ml streptomycin and in the
presence of 150μg/ml geneticin sulphate (G418; Kumar et
al. 2007). These GFP-transfected parasites were used to
determine the IC50 of the compound by flow cytometric
analysis as established by us (Singh and Dube 2004). In
vitro antileishmanial activity was expressed as IC50 which
is the concentration that resulted in 50% inhibition of
parasites (Kumar et al. 2008).
Candidate compound Compound [(4-fluoro-phenyl)-6-
methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic
acid ethyl ester] was prepared by our earlier reported
method (Fig. 1; Dwivedi et al. 2005).
Cytotoxicity test upon cells The toxicity of compound was
evaluated on non-activated, freshly isolated normal human
peripheral blood mononuclear cells (PBMC) isolated
according to standard protocol (Fuss et al. 2009). PBMC
concentration was adjusted to 2×10
6viable cells/ml after
estimation of viability by trypan blue exclusion assay.
Viability was consistently greater than 96%. Cells (1×10
6)
were incubated with various concentrations of the com-
pound at 37°C in 5% CO2 for 24 h. The mean percentage of
post treatment viable cells relative to control was evaluated
by epifluorescence microscopy (Leica) using Live-Dead
Cell Staining Kit (BioVision).
Antileishmanial activity in vivo Syrian golden hamsters
(Mesocricetus auratus) were infected intracardially with
1×10
7 amastigotes isolated from the spleen of heavily
infected donor hamsters. Splenic biopsies were carried out
on day25 p.i. for assessing the status of infection by
making spleen dab smears. Animals having ten to 15
amastigotes per 100 spleen cell nuclei were selected and
used for screening purposes. Animals were treated orally
with the compound at 12.5, 25, 50, 75 and 100 mg/kg dose
for five consecutive days. Splenic biopsies were again
performed on day7 post treatment, and the parasite burden
in treated and untreated group was quantitated. Percent
2 5
3
Fig. 1 Chemical structure of
(4-fluoro-phenyl)-6-methyl-2-
thioxo-1,2,3,4
tetrahydropyrimidine-5-
carboxylic acid ethyl ester
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following formula:
PI ¼
AT   100
IT   TI
where PI is percent inhibition; AT is actual number of
amastigotes per 100 spleen cell nuclei in treated animals; IT
is initial number of amastigotes per 100 spleen cell nuclei
in treated animals; and TI is times increase in untreated
control animals. The use of animals for all the experiments
was in compliance with the relevant guidelines of the
institutional animal ethics committee.
DNA content (percent sub-G1) analysis by flow cyto-
metry L. donovani promastigotes (2×10
6 log phase) over-
expressing PTR1–GFP chimaera treated with compound
(98μM, 0–48 h) were harvested by centrifugation at
2,000×g, for 5 min at 4°C. Cells were washed once in
1 ml phosphate-buffered saline (PBS) and then fixed by
incubation in 70% ethanol:30% PBS for 1 h at 4°C. Prior to
analysis, fixed cells were harvested by centrifugation at
1,000×g, for 10 min at 4°C, washed in 1 ml PBS and then
resuspended in 1 ml PBS with RNAse A (100μg/ml) and
PI at 10 mg/ml. The cells were incubated at 25°C for
45 min and then analysed by using a Becton Dickinson
FACSCalibur flow cytometer. Ten thousand cells were
analysed for each sample. Cell cycle distribution was
modelled using the ModFit LT software package (Verity
Software House; Hedley et al. 1993).
Flow cytometric analysis of externalised phosphatidyl
serine Externalisation of phosphatidyl serine (PS) on the
outer membrane of promastigotes upon treatment with
compound was determined by using annexin V-PE. Briefly,
2×10
6 log phase L. donovani promastigotes overexpressing
PTR1–GFP chimaera were incubated with compound
(98μM, 24 h); cells were centrifuged at 2,000×g for
5 min at 4°C, washed twice in phosphate-buffered saline
(0.02 M, pH7.2, PBS) and resuspended in annexin V-PE
binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM
CaCl2; pH7.4). Annexin V-PE was then added according to
the manufacturer’s instructions and incubated for 30 min in
the dark at 20–25°C. Acquisition was done on a FACSCa-
libur flow cytometer (BD) and analysed with CellQuest
software.
Measurement of mitochondrial membrane potential Mito-
chondrial damage upon treatment with compound in L.
donovani promastigotes overexpressing PTR1–GFP chi-
maera was assessed by flow cytometry using a cell-
permeable dye, MitoTracker deep red. MitoTrackers are
aldehyde fixable cationic lipophilic fluorochrome that
passively diffuses through the plasma membrane of viable
cells and is selectively sequestered in mitochondria with an
active membrane potential and permits the examination of
the membrane potential in adherent cells (Haugland 1996).
L. donovani promastigotes were treated with compound
(98μM, 0–5 h), washed in PBS and loaded in dark for
30 min with MitoTracker (10μM) as per the manufacturer’s
instructions (Molecular Probes). Analysis for mean fluores-
cence intensity was done using FACSCalibur and CellQuest
software.
Analysis of nuclear morphology Oligonucleosomal frag-
mentation in L. donovani promastigotes (overexpressing
PTR1–GFP chimaera) treated with the compound was
identified microscopically using the fluorescent nucleic
acid-specific stain PI. Briefly, promastigotes were incubated
with compound (98μM0 –48 h), cells were then centri-
fuged at each time point, and the resultant pellet was loaded
with PI (10μg/ml) for 30 min at 20–25°C, attached on
poly-L-lysine coated glass slides, mounted in glycerol
containing 1,4-diazabicyclo octane and examined under a
confocal microscope (Leica, Germany). Untreated promas-
tigotes at each corresponding time point were also
processed and analysed similarly. At least 20 microscopic
fields were observed for each sample.
Oligonucleosomal DNA fragmentation assay To analyse
the presence of DNA fragments generated as a function of
cell death, total cellular DNA from L. donovani promasti-
gotes exposed to compound (98μM, 0–48 h) were isolated
according to manufacturer’s instructions (Bio-Rad).
Extracted DNA was quantified spectrophotometrically by
the absorbance ratio of 260/280 nm, and DNA (10μg/lane)
was separated by electrophoresis on 1% agarose gel
containing ethidium bromide in Tris base–boric acid–EDTA
buffer (50 mM; pH8.0) for 1.5 h at 75 V, visualised under
UV light and photographed using a gel documentation
system (GelDoc 2000, Bio-Rad).
Statistical analysis
The data are presented as mean±SD. The statistical
significance of differences in percentage between treated
and untreated was analysed by one-way analysis of
variance using GraphPad Prism software.
Results
Determination of cytotoxicity upon cells The toxicity data
against host cell macrophages was gathered before testing
the compound against the intracellular pathogen in vivo.
Cytotoxic potential of compound at 30 and 100μMo n
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toxicity against macrophages (Fig. 2). More importantly,
absence of shared toxicity to PBMC has increased its
therapeutic ratio.
Determination of the IC50 of compound-mediated death in
vivo The compound exhibited excellent in vivo antileish-
manial efficacy by oral route against established infection
of L. donovani. It imparted 80.4±2.4% inhibition of
parasite at 50 mg/kg dose. At higher doses of 75 and
100 mg, it exhibited still higher (85.7±5.4% and 93.5±
4.5%, respectively) growth inhibitory effect. An ED50 of
36.3 mg/kg body weight was obtained (Fig. 3). This
compound was devoid of any toxicity towards animals as
no mortality was seen during the course of treatment.
Compound induces sub-G0/G1 phase cell cycle arrest in L.
donovani promastigotes The least expensive and most
rapid discrimination of apoptotic cells is based on DNA
content analysis. This is an established approach for
screening drug effects in vitro (Darzynkiewicz et al.
1997). The DNA content of cells is measured by the ability
of PI to bind stoichiometrically to DNA under appropriate
staining conditions. The nuclei of these stained cells are
Control
After 100 µM of compound treatment
Fig. 2 Cytotoxicity assay on PBMCs from human peripheral blood;
PBMCs were isolated from human peripheral blood. Cells were
incubated with various concentrations of the compound. The mean
percentage of post treatment viable cells relative to control was
evaluated by epifluorescence microscopy (Leica) using Live-Dead
Cell Staining Kit (BioVision). Magnification ×40. a Differential
interference contrast image of isolated macrophages. b Live cells
with green stain (flourescein isothiocyanate). c Dead cells with red
stain (PI). As very low or no cells were dead, no red spots were found.
Upper panels show the images without any treatment, and lower
panels show the images after 100μM of compound treatment for 24 h
Fig. 3 Analysis of antileishmanial activity of compound in vivo.
Syrian golden hamsters (M. auratus) were infected intracardially with
1×10
7 amastigotes isolated from the spleen of heavily infected donor
hamsters. Animals were treated orally with the inhibitor at 12.5, 25,
50, 75 and 100 mg/kg dose for five consecutive days. Splenic biopsies
were performed on day7 post treatment, and the parasite burden in
treated and untreated groups were quantitated
1320 Parasitol Res (2009) 105:1317–1325evaluated individually for DNA content by flow cytometry.
The results are displayed graphically as a histogram in
which the fluorescence emitted by each nucleus is directly
proportional to its DNA content. In addition to the
enumeration of apoptotic cells offered by this method, the
cell cycle-specific effects can easily be recognised from
DNA content histograms of the nonapoptotic cell popula-
tions. We performed a cell cycle analysis by flow cytometry
after PI staining of the parasites incubated for 0–48 h at
IC50 (98μM) of the compound. To determine the apoptotic
population, the sub-G0/G1 peak was measured. Figure 4
shows the DNA cell cycle histograms of parasites before
and after treatment of the compound. DNA that is
fragmented is observed in a sub-G1 peak in the DNA
histograms of the treated parasites. The DNA histograms
show that DNA fragments increased significantly in
promastigotes from 24 (32%) to 48 h (48%) compared to
control. This suggests that this analogue could initiate late
events of PCD such as nuclear condensation and DNA
nicking.
L. donovani promastigotes show externalisation of phos-
phatidylserine following treatment with compound In meta-
zoan and unicellular cells, ubiquitous alteration is the
translocation of phosphatidylserine from the inner side to
the outer layer of the plasma membrane during PCD (Mehta
and Shaha 2004). Annexin V, a Ca
2+-dependent phospho-
lipid binding protein with affinity for phosphatidylserine, is
routinely used to label externalisation of phosphatidylser-
ine. Hence, for the determination of the mechanism of cell
death triggered by this compound via apoptosis (annexin V
positive), compound-treated L. donovani promastigotes
overexpressing PTR1–GFP chimaera (98μM, 24 h) were
stained with annexin V-PE. A significant percentage (46%)
of promastigotes of treated cells (3 h) stained positive for
both GFP and annexin V as shown in upper right quadrant
as compared to only 2.0% in untreated cells (Fig. 5). The
percentage of double-stained cells (upper right quadrant)
indicated that this inhibitor exerts its leishmanicidal activity
primarily via apoptosis in Leishmania cells overexpressing
PTR1. The increase in annexin V positive cells increased
Control  32%  
SubG1 
48%  
SubG1 
Fig. 4 DNA content (percent
sub-G1) analysis of cells upon
treatment with compound. Log
phase L. donovani promasti-
gotes (overexpressing PTR1–
GFP chimaera) were incubated
with inhibitor (98μM) for 24
and 48 h, stained with PI and
analysed by flow cytometry. A
significant sub-G1 was observed
(blue). This is a representative
profile of at least three
experiments
Fig. 5 Externalisation of phos-
phatidylserine in L. donovani
promastigotes overexpressing
PTR1 upon treatment with
compound. Log phase
L. donovani promastigotes
(overexpressing PTR1–GFP
chimaera) were incubated with
compound (98μM) for 24 h,
stained with annexin V-PE and
analysed by flow cytometry.
This is a representative profile
of at least three experiments
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and then decreased a bit. Most probably, decrease in plasma
membrane integrity in treated cells is responsible for this.
Compound induces sustain depolarisation of mitochondrial
membrane potential The loss of mitochondrial membrane
potential is a characteristic feature of metazoan apoptosis
and has been observed to play a key role in drug-induced
death in protozoans such as Leishmania (Sen et al. 2004).
L. donovani promastigotes overexpressing PTR1–GFP
chimaera were treated with compound. Following treat-
ment, membrane potential was determined by cytofluoro-
metric measurement of the mitochondrial dependent uptake
and retention of MitoTracker deep red (CMXRos) into
mitochondria. CMXRos is an aldehyde fixable cationic
lipophilic fluorochrome that passively diffuses through the
plasma membrane of viable cells and is selectively
sequestered in mitochondria with an active membrane
potential and permits the examination of the membrane
potential in cells (Haugland 1996; Shibayama-Imazu et al.
2006). PI staining was utilised to gate the necrotic cell
population and debris from the viable cell population
(Darzynkiewicz et al. 1997). Treatment with 98μM
compound resulted in reduction of MitoTracker positive
cells from 96.54% at 30 min to 9.86% in 5 h when
compared to DMSO (0.25%)-treated controls (96.8%;
Fig. 6). A higher concentration of annexin V and
MitoTracker were used to boost intracellular signalling.
Analysis of chromatin condensation in L. donovani pro-
mastigotes following treatment with compound During
programmed cell death, the cleavage patterns of genomic
DNA are typical of internucleosomal DNA digestion by
endonucleases and are considered as a hallmark of
apoptosis that is preceded by chromatin condensation and
nuclear blebbing (Verma and Dey 2004). In untreated
promastigotes (control) stained with PI, the cells appeared
with discrete two red spots representing mitochondria and
nucleus. In treated promastigotes (24 h, 98μM), the spot of
mitochondria seems to be like the control cells, whereas the
nuclear spot became discrete and appeared like blebbed
nuclei. With increase in treatment time (48 h), promastigote
morphology was totally altered. The shape became round
and ovoid, the spot of the mitochondria abolished,
indicating dyskinetoplastidy. More interestingly, the nucle-
us was represented by numerous spots indicating nuclear
condensation (Fig. 7).
OligonucleosomalDNAfragmentationanalysisofL. donovani
promastigotes following treatment with compound Analysis
of integrity of genomic DNA (gDNA) by DNA laddering
strengthened the claim that the compound induces active
death process. A ladder-like pattern of oligonucleosomal
DNA fragments was observed after 24 h of treatment (Fig. 8).
Discussion
We identified a potent inhibitor of L. donovani PTR1 from
a collection of proprietary dihydropyrimidone (DHPM)
derivatives with DHFR activity. Although PTR1 and DHFR
are unrelated at the primary sequence level and structurally
as well, both enzymes are inhibited by compounds
containing the 2,4-diaminopyrimidine scaffold (Hardy et
al. 1997). Recombinant enzyme inhibition as well as
structure activity relationship established the high specific-
Fig. 6 Changes in mitochondri-
al membrane potential following
treatment. Log phase L. dono-
vani promastigotes (overex-
pressing PTR1–GFP chimaera)
were incubated with compound
(98μM) for 0–5 h, loaded in
dark for 30 min with Mito-
Tracker (10μM) and analysed
by flow cytometry. This is a
representative profile of at least
three experiments
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values determined on recombinant enzymes can be ques-
tionable. Thereby, intracellular amastigotes overexpressing
PTR1 tagged at the N-terminal with GFP were used to
establish the leishmanicidal activity in vitro in mouse
macrophages (Green Screen Assay). Using this system,
we obtained an IC50 of 23μM in amastigotes. Our study
thus demonstrates the utility of cell-based assays using gene
overexpression as a useful chemical genetic screening
system targeting both genotoxic and cytotoxic events
within the cell. This compound showed a high therapeutic
index in vivo and can give ~93% decreases in parasite
burden in L. donovani-infected hamsters. This dosage
eliminated ~93% of parasites (i.e. that was essentially
curative) and did not also result in >10% mean weight loss,
which we arbitrarily chose as an indication of drug toxicity.
The nonspecific toxicity against host cells highlights the
important relationship between structure and biological
selectivity of compounds. The compound showed leishma-
nicidal effect on L. donovani promastigotes which was
enhanced on intracellular organisms both in vitro and in
vivo model, suggesting that interaction of the compound
with host cell or with cellular events is important for its
inhibitory effect. The efficacy of this inhibitor is due to
excellent cell permeability. Our molecule resembles mon-
astrol, a structurally rather simple DHPM, which is the only
cell-permeable molecule currently considered as a lead for
the development of new anticancer drug (Kapoor et al.
2000). This compound exhibited superior oral antileishma-
nicidal activity. Orally active long-lasting antihypertensive
agents of DHPM specificity have been reported (Wang et al.
2006) resulting from the increased chemical stability of the
urea functionality. Because of the pharmacological potency
of the DHPM scaffold, dihydropyrimidines with important
biological properties have been cited (Darzynkiewicz et al.
1997; Hardy et al. 1997; Haugland 1996; Green and
Kroemer 1998; Gottlieb 2000). The heterocyclic scaffold
of this compound is found in natural marine alkaloid
Fig. 8 Time course of DNA
fragmentation observed follow-
ing treatment with compound.
gDNA (10μg) isolated from L.
donovani promastigotes, which
have been treated with com-
pound (98μM) for 24 h and
48 h, were resolved on 1%
agarose gel. First lane positive
control consisting of lyophilised
apoptotic cells, second lane
negative control consisting of
cells without any treatment,
third lane 24 h of compound
treatment, fourth lane,4 8ho f
compound treatment
Fig. 7 Analysis of nuclear morphology-oligonucleosomal fragmenta-
tion in L. donovani promastigotes (overexpressing PTR1–GFP
chimaera) treated with the compound was identified microscopically
using the fluorescent nucleic acid-specific stain propidium iodide. Log
phase promastigotes were incubated with compound (98μM) for 24
and 48 h, respectively, adhered on poly-L-lysine coated cover slips and
analysed under confocal microscope. Magnification ×40. Images are
representative of one of three similar results
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getting the biologically active natural product. Having
established the leishmanicidal effect of compound on L.
donovani in promastigotes and amastigotes, we sought to
establish the type of death caused by this compound. On
treatment of L. donovani promastigotes with compound,
sub-G1 peak characteristic of apoptosis occurred at 24 h.
Different apoptosis markers, such as externalisation of PS
and nuclear DNA fragmentation, were observed in 24 h.
The induction of mitochondrial dysfunction in the apoptotic
process was apparent in the MitoTracker Red study results.
The study of mitochondrial potential has become a focus of
apoptosis regulation as many investigations demonstrate a
major functional impact of mitochondrial alterations on
apoptosis (Gottlieb 2000). Many antileishmanial drugs (Sen
et al. 2004; Scarlett et al. 2000; Sudhandiran and Shaha
2003; Santa-Rita et al. 2006) cause a significant fall in
membrane potential (Haugland 1996). In higher eukaryotic
cells, apoptosis often occurs downstream of the death signal
by protease activation, leading to endonuclease ignition
(Green and Kroemer 1998). In these instances, cysteine
proteases of the caspase family, Ca
2+-sensitive calpains or
proteasomes can initiate cell death. We are tempted to
speculate that release of death factors from mitochondria of
promastigotes overexpressing PTR1 as a result of treatment
with compound is causing apoptosis without involving
caspases. This analogy is based on our earlier confirmation
that degradation of the PTR1 protein is not by the usual
multivesicular tubule lysosome pathway but is mediated by
the proteasome (Kumar et al. 2007). Existence of a caspase-
independent apoptotic pathway to antimonial drugs, in
Leishmania, has been reported (Holzmuller et al. 2002; Lee
et al. 2002;S e r e n oe ta l .2001). There is a general
consensus that DNA is the main target for most, if not all,
apoptotic drugs. In the present study, we found that
compound-induced cell death was accompanied by dyskine-
toplastidy, i.e. loss of kDNA network, and was associated
with extensive nuclear DNA fragmentation. This endonucle-
ase activity could be due to a coordinated process of
intracellular protein degradation mediated by the protea-
some, leading to nuclear DNA fragmentation. In conclusion,
on screening DHPM derivatives with DHFR specificity, we
have identified a lead compound with remarkable in vivo
activity. The interaction of this compound with its biological
target viz. PTR1 at the molecular level has been affirmed.
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